To explore the underlying mechanism for CD8+PD1+ T cells to trigger the development of HCC, Pfister et al.1 adopted scRNA-seq and high-parametric flow cytometry to further characterize CD8+PD1+ T cells after anti-PD1 treatment. Here, PDCD1 is linked to hepatocellular carcinoma.